Better Buy: Fidelity Health Care ETF (FHLC) or iShares Biotechnology ETF (IBB)?
FHLC offers broader sector exposure at a 0.08% expense ratio, compared with IBB's concentrated biotech focus at 0.44%, but IBB delivered stronger 1-year returns despite higher volatility.